These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 24259523
1. Longitudinal analysis of distribution and function of plasmacytoid dendritic cells in peripheral blood and gut mucosa of HIV infected patients. Lehmann C, Jung N, Förster K, Koch N, Leifeld L, Fischer J, Mauss S, Drebber U, Steffen HM, Romerio F, Fätkenheuer G, Hartmann P. J Infect Dis; 2014 Mar; 209(6):940-9. PubMed ID: 24259523 [Abstract] [Full Text] [Related]
2. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection. Jenabian MA, El-Far M, Vyboh K, Kema I, Costiniuk CT, Thomas R, Baril JG, LeBlanc R, Kanagaratham C, Radzioch D, Allam O, Ahmad A, Lebouché B, Tremblay C, Ancuta P, Routy JP, Montreal Primary infection and Slow Progressor Study Groups. J Infect Dis; 2015 Aug 01; 212(3):355-66. PubMed ID: 25616404 [Abstract] [Full Text] [Related]
3. Short communication: Plasmacytoid dendritic cells from HIV-1 Elite Controllers maintain a gut-homing phenotype associated with immune activation. Li H, Goepfert P, Reeves RK. AIDS Res Hum Retroviruses; 2014 Dec 01; 30(12):1213-5. PubMed ID: 25387330 [Abstract] [Full Text] [Related]
4. Th17 cells, HIV and the gut mucosal barrier. Dandekar S, George MD, Bäumler AJ. Curr Opin HIV AIDS; 2010 Mar 01; 5(2):173-8. PubMed ID: 20543596 [Abstract] [Full Text] [Related]
5. Robust interferon-α and IL-12 responses by dendritic cells are related to efficient CD4+ T-cell recovery in HIV patients on ART. Tan DB, Yong YK, Lim A, Tan HY, Kamarulzaman A, French M, Price P. Clin Immunol; 2011 May 01; 139(2):115-21. PubMed ID: 21429806 [Abstract] [Full Text] [Related]
9. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection. Mak G, Zaunders JJ, Bailey M, Seddiki N, Rogers G, Leong L, Phan TG, Kelleher AD, Koelsch KK, Boyd MA, Danta M. Front Immunol; 2021 May 01; 12():688886. PubMed ID: 34135912 [Abstract] [Full Text] [Related]
10. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment. Briceño O, Pinto-Cardoso S, Rodríguez-Bernabe N, Murakami-Ogasawara A, Reyes-Terán G. PLoS One; 2016 May 01; 11(11):e0166496. PubMed ID: 27898686 [Abstract] [Full Text] [Related]
11. Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment. Hua W, Jiao Y, Zhang H, Zhang T, Chen D, Zhang Y, Chen X, Wu H. Immunol Invest; 2012 May 01; 41(1):1-14. PubMed ID: 21563924 [Abstract] [Full Text] [Related]
12. Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-α and differentiate into functional killer pDCs under HIV activation. Barblu L, Machmach K, Gras C, Delfraissy JF, Boufassa F, Leal M, Ruiz-Mateos E, Lambotte O, Herbeuval JP, ANRS EP36 HIV Controllers Study Group. J Infect Dis; 2012 Sep 01; 206(5):790-801. PubMed ID: 22693234 [Abstract] [Full Text] [Related]
13. Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection. Naidoo KK, Ndumnego OC, Ismail N, Dong KL, Ndung'u T. Front Immunol; 2021 Sep 01; 12():738743. PubMed ID: 34630420 [Abstract] [Full Text] [Related]
14. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA. Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, Landay A, Haubrich R. J Infect Dis; 2006 Jul 01; 194(1):29-37. PubMed ID: 16741879 [Abstract] [Full Text] [Related]
15. Multi-functional plasmacytoid dendritic cells redistribute to gut tissues during simian immunodeficiency virus infection. Li H, Gillis J, Johnson RP, Reeves RK. Immunology; 2013 Oct 01; 140(2):244-9. PubMed ID: 23746074 [Abstract] [Full Text] [Related]
16. Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients? Abad-Fernández M, Gutiérrez C, Madrid N, Hernández-Novoa B, Díaz L, Muñoz-Fernández MA, Moreno S, Vallejo A. HIV Med; 2015 Jan 01; 16(1):15-23. PubMed ID: 24831847 [Abstract] [Full Text] [Related]
17. Expression of TIM-3 on Plasmacytoid Dendritic Cells as a Predictive Biomarker of Decline in HIV-1 RNA Level during ART. Font-Haro A, Janovec V, Hofman T, Machala L, Jilich D, Melkova Z, Weber J, Trejbalova K, Hirsch I. Viruses; 2018 Mar 28; 10(4):. PubMed ID: 29597250 [Abstract] [Full Text] [Related]
18. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. Sereti I, Estes JD, Thompson WL, Morcock DR, Fischl MA, Croughs T, Beq S, Lafaye de Micheaux S, Yao MD, Ober A, Wilson EM, Natarajan V, Imamichi H, Boulassel MR, Lederman MM, Routy JP. PLoS Pathog; 2014 Jan 28; 10(1):e1003890. PubMed ID: 24497828 [Abstract] [Full Text] [Related]
19. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation. Rajasuriar R, Booth D, Solomon A, Chua K, Spelman T, Gouillou M, Schlub TE, Davenport M, Crowe S, Elliott J, Hoy J, Fairley C, Stewart G, Cameron P, Lewin SR. J Infect Dis; 2010 Oct 15; 202(8):1254-64. PubMed ID: 20812848 [Abstract] [Full Text] [Related]
20. Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals. Fernandes SM, Pires AR, Ferreira C, Foxall RB, Rino J, Santos C, Correia L, Poças J, Veiga-Fernandes H, Sousa AE. J Infect Dis; 2014 Aug 15; 210(4):630-40. PubMed ID: 24604817 [Abstract] [Full Text] [Related] Page: [Next] [New Search]